A Randomised Study to Compare Metal Ion Release and Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-Metal or a Metal-on-Metal Bearing
This study has been terminated.
(Study progress very slow therefore terminated as other projects underway to investigate the same research question which will deliver results earlier)
Sponsor:
DePuy International
Information provided by:
DePuy International
ClinicalTrials.gov Identifier:
NCT00873444
First received: March 19, 2009
Last updated: September 1, 2011
Last verified: September 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to monitor the performance and compare the metal ion release of two bearing combinations, ceramic-on-metal and metal-on-metal in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the bearing combinations and will be evaluated at regular intervals using, patient, clinical and x-ray assessments. Patients will also have blood samples taken at regular intervals to allow the metal ion levels to be determined.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis Post-traumatic Arthritis Collagen Disorders Avascular Necrosis Congenital Hip Dysplasia Slipped Capital Femoral Epiphysis |
Device: Pinnacle™ Acetabular System |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Randomised, Controlled, Prospective, Multi-Centre, Post Market Surveillance Study Comparing a Ceramic-on-Metal Bearing and a Metal-on-Metal Bearing in Subjects Requiring Primary Total Hip Arthroplasty for Non-Inflammatory Degenerative Joint Disease |
Resource links provided by NLM:
Further study details as provided by DePuy International:
Primary Outcome Measures:
- Cobalt metal ion levels in the blood at 2 years post surgery [ Time Frame: 2 years post-surgery ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Kaplan-Meier survivorship calculations [ Time Frame: Annually ] [ Designated as safety issue: Yes ]
- Oxford Hip Score [ Time Frame: Annually ] [ Designated as safety issue: No ]
- UCLA Score [ Time Frame: Annually ] [ Designated as safety issue: No ]
- Pain Visual Analogue Scale [ Time Frame: Annually ] [ Designated as safety issue: Yes ]
- Harris Hip Score [ Time Frame: 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery ] [ Designated as safety issue: No ]
- Radiographic analysis [ Time Frame: 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery ] [ Designated as safety issue: No ]
- Blood metal ion levels [ Time Frame: pre-discharge, 6 weeks, 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 190 |
| Study Start Date: | July 2006 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1) Ceramic-on-Metal Bearing
A cementless acetabular cup with ceramic liner for use in total hip replacement
|
Device: Pinnacle™ Acetabular System
A cementless acetabular cup with ceramic liner for use in total hip replacement
|
|
Active Comparator: 2) Metal-on-Metal Bearing
A cementless acetabular cup with metal liner for use in total hip replacement
|
Device: Pinnacle™ Acetabular System
A cementless acetabular cup with metal liner for use in total hip replacement
|
Eligibility| Ages Eligible for Study: | 20 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Skeletally mature male or female subjects, aged between 20 and 75 years inclusive at the time of surgery.
- Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
- Subjects who, in the opinion of the Investigator, are able to understand this investigation co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
- Subjects undergoing unilateral primary total hip replacement who are suitable for a cementless acetabular component and whose femoral and acetabular bone stock is suitable to receive implants, without the requirement for a bone graft.
- Subjects with radiographic evidence and primary diagnosis of non-inflammatory degenerative joint disease (NIDJD).
- Subjects with a pre-operative Harris Hip Score of less than or equal to 70 and a pain rating of at least moderate for the operative hip.
Exclusion Criteria:
- Subjects who, in the opinion of the Investigator, have an existing condition, such as active infections, highly communicable diseases, neurological or musculoskeletal disorders that might affect weight-bearing and metastatic or neoplastic disease, that would compromise their participation and follow-up in this study.
- Subjects who currently have other metallic foreign bodies including trauma products and joint arthroplasties, unless known to be titanium alloy only.
- Patients who have received a total hip arthroplasty in the contralateral hip within the previous 12 months unless known to be titanium alloy only.
- Subjects who have undergone previous hip surgery on the operative hip (including previous hip/surface replacements, resection arthroplasty or surgical fusion of the hip).
- Subjects requiring a simultaneous bilateral hip operation.
- Subjects who, in the opinion of the investigator, will possibly require a separate joint replacement operation within the next two years, including revision operations.
- Subjects with an acute femoral neck fracture of the operative hip.
- Subjects who have undergone above knee amputation of the contralateral and/or ipsilateral leg.
- Subjects with compromised renal function.
- Subjects with a known allergy to metal (eg, jewellery).
- Subjects with an occupational exposure to cobalt, chromium, molybdenum, titanium or nickel.
- Subjects who have ingested medication or vitamins containing cobalt, chromium, molybdenum, titanium or nickel within the last 12 months, or intend to ingest such substances over the next 2 years.
- Subjects who have undergone systemic steroid therapy, excluding inhalers, in the three months prior to surgery.
- Women who are pregnant.
- Subjects who are prisoners, known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
- Subjects who have participated in a clinical study with an investigational product in the last 12 months.
- Subjects who are currently involved in any injury litigation claims.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Roy Harvey, Clinical Research Manager, DePuy International Ltd |
| ClinicalTrials.gov Identifier: | NCT00873444 History of Changes |
| Other Study ID Numbers: | CT00/37 |
| Study First Received: | March 19, 2009 |
| Last Updated: | September 1, 2011 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by DePuy International:
|
Hip Cementless Ceramic-on-Metal Metal-on-Metal |
Additional relevant MeSH terms:
|
Arthritis Collagen Diseases Hip Dislocation, Congenital Necrosis Osteonecrosis Osteoarthritis Joint Diseases |
Musculoskeletal Diseases Connective Tissue Diseases Musculoskeletal Abnormalities Congenital Abnormalities Pathologic Processes Bone Diseases Rheumatic Diseases |
ClinicalTrials.gov processed this record on June 17, 2013